UPDATE 3-Double blow for Roche as breast cancer, Alzheimer's studies fail

December 19, 2014 2:09 PM

15 0

* MorphoSys down 9.3 pct, ImmunoGen off 27 pct in premarket (Adds latest shares, more reaction, Breakingviews link)

ZURICH/LONDON, Dec 19 (Reuters) - Roche suffered a double blow on Friday as two clinical studies of drugs for breast cancer and Alzheimer's disease failed, sparking the biggest percentage fall in its stock in five years.

Read more

To category page